Zentalis Pharma Stock (NASDAQ: ZNTL) stock price, news, charts, stock research, profile.
Open | $4.06 |
Close | - |
Volume / Avg. | 646.68K / 1.39M |
Day Range | 3.97 - 4.43 |
52 Wk Range | 3.27 - 29.03 |
Market Cap | $313.88M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | 27.37% |
Days to Cover | 1.9 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Zentalis Pharma (NASDAQ:ZNTL) through any online brokerage.
Other companies in Zentalis Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Tectonic Therapeutic (NASDAQ:TECX), bluebird bio (NASDAQ:BLUE), Inovio Pharmaceuticals (NASDAQ:INO) and Adaptimmune Therapeutics (NASDAQ:ADAP).
There is no analysis for Zentalis Pharma.
Zentalis Pharma has a consensus price target of $21.70.
The stock price for Zentalis Pharma (NASDAQ: ZNTL) is $4.42 last updated Today at July 16, 2024 at 2:32 PM EDT.
There are no upcoming dividends for Zentalis Pharma.
Zentalis Pharma’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Zentalis Pharma.
Zentalis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.